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Background: Emodin is the main active component of rhubarb, which has
demonstrated many beneficial effects against inflammation. Nanosilver is an effective
antimicrobial agent. The present study was designed to observe the effects of Emodin
combined with silver nanoparticles (E/S) on sepsis protection and related mechanism.
Methods: E/S was prepared by loading different concentrations of Emodin on nanosilver
and cytotoxicity of E/S were determined by suphorhodamine B assays. Anti-microbial
activities of E/S were assayed by direct interaction with various common pathogens
and anti-adhesive activites of E/S on leukocytes with endothelial cells were assayed
by biochemical analysis. Next, inflammatory cell enumeration, inflammatory mediators
in bronchoalveolar lavage fluid (BALF) and endothelial cell function were analyzed on a
clinically relevant model of sepsis induced by cecal ligation and puncture (CLP) after E/S
administration. The effects of E/S on NF-κB and p38 were also examined by western
blot.
Results: E/S exhibited little cytotoxicity action on endothelial cells and significant
inhibitory activities against all tested common microorganisms and adherence between
leukocyte and endothelial cells. E/S induced anti-sepsis protection mainly mediated by
inhibition of inflammatory cells infiltration, down-regulation of TNF-alpha, IL-8 and lactic
dehydrogenase (LDH), and inhibition of NF-κB and p38 pathways in mice 24 h post-CLP.
Conclusion: Our data suggest that E/S has strong anti-sepsis effects, which was
related with anti-inflammatory protection and thereby promote survival following sepsis
challenge.
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INTRODUCTION
Severe sepsis and septic shock are common fatal diseases with an extremely high morbidity rate for
overwhelming lung inflammation in intensive care unit (Mikkelsen et al., 2013) and management
of patients relies mainly on early, right and rapid therapeutic measures including administration of
appropriate antibiotics, control of infection source, and resuscitation with intravenous fluids and
vasoactive drugs when needed (Cohen et al., 2015). Accumulating evidence suggests that a large
number of pathogens and subsequent the production of a large quantity of inflammatory mediators
such as tumor necrosis factor-α (TNF-α), interleukin-8 (IL-8), reactive oxygen species (ROS) and
nitric oxide (NO) etc., mainly through nuclear factor-kappa B (NF-κB) and mitogen-activated
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protein kinase (MAPK) pathways, gets involved in the
pathogenesis of sepsis (Carneiro et al., 2013; Liang et al.,
2014). On one hand, a large number of pathogens enter the blood
stream, release a large number of pathogenic substances and
activate serious systemic inflammatory response. On the other
hand, activation of inflammatory signaling resulted in increasing
adhesion molecules expressions, including intercellular adhesion
molecule (ICAM)-1 and vascular cell adhesion molecule
(VCAM)-1, which play significant roles in migration and cell
adhesion of various inflammatory cells and further damage to
epithelial and endothelial cells in the lung (Rajasingh et al., 2006;
Zhang et al., 2006). Thus, Sepsis results from the combined
effect of a virulent infection and powerful host response to the
infection. Although great efforts has been made in the inhibition
of exaggerated inflammation and promotion of endothelial
protection, the treatments have still been very limited and cause
high mortality rates worldwide.
Modern pharmacology has demonstrated that the active
ingredient Emodin of rhubarb exhibits a series of pharmaceutical
activities against inflammation, tumors, atherosclerosis and
allergies (Wang et al., 2008, 2012; Xiong et al., 2011).
Furthermore, it has been found that the anti-inflammatory effect
of emodin results from inhibition of the p38 MAPK and NF-
κB signaling pathway (Xue J. et al., 2015). Recently, nanosilver
has received considerable attention as antimicrobial agents due
to its strong anti-microbial activities (Rai et al., 2015), which
is especially beneficial against resistant bacteria such as E. coli,
P. aeruginosa and A. baumanii etc (Wang et al., 2015). However,
in light of toxicological research, nanosilver has an adverse
effect by induction of oxidation stress, contributing to cytotoxic
and genotoxic injuries (Wa˛sowicz et al., 2011). The value of
combined nanosilver with emdoin on sepsis is still unclear.
Thus, the purpose of this study was to elucidate whether E/S
could ameliorate a clinically relevant sepsis and its corresponding
mechanism.
MATERIALS AND METHODS
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health of
China. The protocol was approved by the Committee on
the Ethics of Animal Experiments of the University of Xi’an
JiaotongUniversity (Permit Number: 2015-152). All surgery were
performed under sodium pentobarbital anesthesia, and all efforts
were made to minimize risks.
Synthesis of E/S
The nanosilver particles were purchased from Alfa Aesar
Biotechnology Ltd. (Tianjin, China) with the mean diameter
obtained and evaluated by scanning electron microscope (SEM)
was 30 nm. Emodin (molecular weight: 270.24) were obtained
from Chengdu Biopurify Phytochemicals Ltd. (Chengdu, China)
with a purity of at least 99%. Aliquots of an initial 5 mg/mL
emodin solution in MeOH were diluted in culture medium to
obtain different concentrations to load in nanosilver.
Cell Toxicity of E/S
Human newborn fetal umbilical veins endothelial cells were
supplied by Modern Analysis and Testing Center of Xi’an
Jiaotong University and seeded into a 96-well plate at a density
of 1×105 cells per well and incubated in DMEM (Hyclone, USA)
supplemented with 12% FBS (GIBCO, USA) at 37◦C in 95% air
and 5% CO2. Different final concentrations of Emodin (1, 10, 20
or 50 µg/ml), Nanosilver (0.1, 1, 5, or 10 µg/ml) and E/S (1, 10,
20 or 50 µg/ml loaded on 1 µg/ml nanosilver) were added into
cultured endothelial cells for 72 h, followed by fixing the cells in
30% of trichloroacetic acid for 2 h at 4◦C. After 3 times of washes,
cells were exposed to 0.5% suphorhodamine B (SRB) solution for
30 min in dark place and subsequently washed with 1% acetic
acid. After drying overnight, Tris-HCl was used to dissolve the
SRB-stained cells and absorbance was measured at 540 nm. Data
are represented as a percentage of control cells.
Assessment of Antimicrobial Activity
Pure cultures of E. coli (ATCC 8739), S. aureus (ATCC 25923),
P. aeruginosa (ATCC 27853), S. aureus (ATCC 25923), and
A. baumanii (ATCC 19606) C. albicans (ATCC 10231) were
obtained from Department of Microbiology of Xi’an Jiaotong
University. E/S was added into Luria-Bertani (LB) culturedmedia
containing 105 colony-forming units of above microbes per
ml (cfu/ml) to a final concentration of 20 µg Emodin/1 µg
nanosilver per ml. The test tubes were incubated at 37◦C for
24 h. After incubation, 100µl of the sample was drawn from each
test tube and inhibition of growth was determined by measuring
absorbance at 600 nm.
Assay of Inflammatory Cell Adherence
Endothelial cells (1 × 105 cells/well) treated with or without LPS
(20 µg/ml) were grown in 24-well plates. The leukocytes were
extracted from blood specimens by using lymphocyte separation
medium in 10 cm centrifuge tubes. After the top interface was
removed and discarded, the leukocytes-containing pellet was
resuspended in PBS. The leukocytes (1 × 105 cells/well) were
then added to the endothelial cell cultures to a total volume
of 0.25 mL and incubated for 4 h at 37◦C. After two washes
with PBS, cells were added 0.25 ml of 0.5% cetrimid to extract
peroxidase (no peroxidase in endothelial cells). Fifty microliter of
supernatant reacted with 150µl of substrate at room temperature
for 30min. The OD492 nm was determined by a microplate
reader. The adherence rate was calculated according to standard
curve obtained by a serial dilutions of inflammatory cells.
Establishment of Animal Models
Fifty male BALB/c mice (weight range, 20–30 g) were randomly
and evenly divided into 5 groups: Control group, CLP group,
Emodin+CLP group (20 mg/kg), E/S+CLP (20 mg/1 mg/kg)
group and nanosilver+CLP (1 mg/kg) group. Briefly, the mice
were anesthetized with 60 mg/kg of pentobarbital sodium, and
a 1-cm midline abdominal incision was then made. The cecum
was ligated, punctured and then returned to the abdominal
cavity according to previous research (Zhu et al., 2015). Control
mice were treated with cecal manipulations without ligation
and puncture. Ten minutes after the operation, mice in CLP
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group were intraperitoneally administered with E/S, Emodin
or nanosilver and mice in comtrol group were administered
same medium without drugs. The animals were given analgesic
(Buprenorphine, i.p. 0.1 mg/kg, ACRIS, Germany) twice per day
and observed every 4 h and put to death by pentobarbital sodium
(i.v. 100 mg/kg).
Immunohistochemistry for Tissue
Morphology
Lungs were inflated, harvested, fixed in 2% paraformaldehyde,
and embedded in paraffin. To visualize the endothelial cells, lung
sections were immunostained with polyclonal rabbit anti mouse
CD31 antibody (Abcam, Cambridge, MA, USA), which were
employed as endothelial markers at a dilution of 1:200. The slides
were washed and incubated with biotinylated goat anti rabbit IgG
for 1 h and washed again. After washing in PBS, the signal was
detected with 3, 3′-diaminobenzidine (Dingguo, China).
Broncho Alveolar Lavage Fluid (BALF) and
Cell Counts
Twenty-four hours later, mice were sacrificed after anesthesia
by pentobarbitone sodium (30 mg/kg i.p.). According to our
previous report, BALFs were collected by cannulating the upper
part of the trachea, by lavage 3 times with 1.0 mL PBS (pH 7.2).
The fluid recovery rate was about 85%. Lavaged samples were
kept on ice. BALFs were centrifuged at 1000× g for 5 min at 4◦C.
The sediment cells were resuspended in 50 µL PBS and stained
with Wright-Giemsa staining. Then, total cells, neutrophils,
macrophages and lymphocytes were counted double-blindly with
a hemocytometer.
Measurement of Media Release in BALF
TNF-alpha (R&D Systems, USA) and IL-8 (R&D Systems, USA)
production in BALFs were measured by ELISA according to the
manufacturer’s instructions. Briefly, Total 100 µL supernatants
were added into 96-well plate and incubated for 1 h, followed by
100 µL enzyme-linked antibodies incubation for 0.5 h at 37◦C.
After washed for 3 times with washing buffer, the chromogenic
reagent was added and incubated for 0.5 h, followed with
2M H2SO4 termination reaction. The 450 nm absorbance was
determined by a microplate reader. Each sample was repeated
three times.
Levels of lactic dehydrogenase (LDH) in the BALFs, which
can be used as a marker of cellular lysis, were determined by
using an LDH assay kit. LDH concentrations were measured by a
microplate reader (Tecan Sunrise, China) at 440 nm.
Western Blot Analysis
Lung tissues were disrupted by homogenization on ice and
centrifuged at 4◦C (10,000 g, 30 min), and the supernatants
were collected. Equal amounts of protein (80 µg) were separated
by 10% SDS-PAGE and transferred to duralose membrane.
Membranes were blocked in 5% (w/v) skim milk for 1 h
and incubated with rabbit against mouse p-p38 MAPK, p38
MAPK, NF-κB p65 (1:1000; Santa cruz, USA) and β-actin
(1:2000; Santa cruz, USA) overnight, respectively. After 3
washes, membranes were incubated with horseradish peroxidase
conjugated secondary antibodies (Santa Cruz, USA) and detected
by enhanced chemiluminescence (Thermo Scientific, USA). Band
intensities were quantified using ImageJ (National Institutes of
Health, USA).
Statistical Analysis
Data were expressed as mean ± SD. t-test was used to
analyze differences between experimental and control groups.
Student-Newman-Kleus method was used for multiple pair-wise
comparisons. All statistical analyses were carried out using the
SPSS version 11.5 for Windows (Chicago, IL, USA). P < 0.05 was
considered statistically significant.
RESULTS
Cytotoxicity of E/S on Endothelial Cells
and Its Anti-microbial and Anti-adhesive
Activities
Under microscope, the cells exhibited little cytotoxicity action
after the administration of different final concentrations of
Emodin. E/S exhibited an obvious cytotoxicity at 50 µg
Emodin/1 µg nanosilver per mL, while nanosilver exhibited a
dose-independent cytotoxicity with an obvious cytotoxicity at
10 µg/mL (Figure 1A). In present study, we choose a final
concentration of 20 µg/mL Emodin and1 µg/mL nanosilver to
construct the combined administration.
Next, we tested the anti-microbial activities of E/S against
common microorganisms in lung infection. Fresh E. coli, S.
aureus, P. aeruginosa, A. baumanii, and C. albicans were grown
in separate LB broths and then E/S (20 µg/ml Emodin and 1
µg/ml nanosilver), Emodin (20 µg/ml) or nanosilver (10 µg/ml)
were inoculated in 1 mL LB broth with a concentration of 105
cfu/mL. All the test tubes cultured at 37◦C for 24 h. Then, 100 µl
of the sample was collected from each test tube and the inhibition
of various treatments on bacterial growth was determined by
measuring OD600 nm. The analyses showed E/S significantly
inhibited all tested microorganisms, while Emodin only inhibited
S. aureus as shown in Figure 1B. Nanosilver also showed
significant inhibition against all tested microorganisms, however,
E/S had much stronger inhibitory effects than nanosilver. So
antimicrobial effect of E/S is greater than when they (E and S)
apply separately.
Next, we measured the effects of E/S on inflammatory
adherence. We found that the adherence of leukocytes to
endothelial cells was low in control cells. After treatment of LPS
(20 µg/ml), leukocyte adherence significantly increased 10-folds.
E/S, E or nanosilver resulted in significant inhibition of leukocyte
adherence to endothelial cells induced by LPS, however, E/S had
much stronger inhibitory effects (Figure 1C).
E/S Ameliorates Lung Inflammation in a
Sepsis Animal Model
All mice in the control group survived. In the CLP-challenge
group, the mice died at 10–12 h, and the lethality reached
100% at 36 h. Pretreatment of the mice with E/S (20
mg/1 mg/kg) significantly decreased the lethality to 30%
(Figure 2A). To observe the pathological changes of the lung
tissues, immunohistochemistry was utilized in our study. As
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FIGURE 1 | Cytotoxicity of E/S on endothelial cells (A, ** p < 0.01 vs. E/S) and its anti-microbial activities (B, ** p < 0.01 vs. Control), and anti-adhesive activities
(C, ** p < 0.01 vs. LPS; ##p < 0.01 vs. Emodin or nanosilver) (n = 3). The effects of E/S on endothelial cells exhibited little cytotoxicity below 50 µg/ml. And E/S
(a final concentration of 20 µg/ml Emodin and 1 µg/ml nanosilver) showed significant inhibitory activities against all tested microorganisms and inflammatory
adherence.
shown in Figure 2B, immunohistochemistry of endothelial
cells revealed that the lung tissues from the sepsis group
demonstrated significantly pathological alterations, including
notable inflammatory cells infiltration, interstitial and intra-
alveolar edema and some collapsed alveoli, which were
attenuated by E/S or Emodin. Moreover, it was shown that the
immune staining of endothelial cells enhanced in E/S group 24 h
post-CLP.
To further evaluate the anti-inflammatory property of E/S,
cell counts in BALF were measured in our study. As shown
in Figure 3A, the number of total cells, neutrophils and
macrophages in BALFs significantly increased in CLP group.
E/S or Emodin group largely reduced the number of total
cells, neutrophils and macrophages in BALFs. The TNF-α levels
(Figure 3B) and IL-8 levels (Figure 3C) in BALFs increased at
24 h post-CLP challenge in a manner that was inhibited by E/S
or Emodin. Under the condition of cellular necrosis or apoptosis,
cells lose cell membrane stabilization and thereafter release LDH.
We next quantified LDH leakage as a parameter of cell membrane
integrity. LDH levels increased in BALF which were subjected to
sepsis. The addition of E/S led to the decrease of LDH release
(Figure 3D).
E/S Inhibited NF-κB and P38 Activation
Studies have shown that the activation of NF-κB and p38 MAPK
triggered the mRNA expression of key inflammatory mediators,
including IL-6, IL-8, and TNFα mRNA (Xue J. et al., 2015).
Thus, NF-κB and p38MAPK-induced activation appear essential
for inflammatory process. To confirm the protective effect of
E/S, western analysis was performed on lung tissues from sepsis
animal models. The data showed that the treatment with E/S
or Emodin inhibited NF-κB and p38 MAPK signaling in CLP-
induced sepsis (Figures 4A,B).
DISCUSSION
Sepsis is a systemic inflammatory response to infection, in
which there is fever or hypothermia, tachycardia, tachypnea,
and evidence of inadequate blood flow to internal organs.
Severe sepsis results in a high mortality rate in critically ill
patients. Over-activated inflammatory cells, mainly neutrophils
and macrophages released a variety of inflammatory mediators
that could directly and indirectly lead to alveolar epithelium and
microvascular endothelium injuries in lung during pathogenesis
of sepsis (Lee et al., 2015). Despite substantial progress being
made in understanding of this disease, the available treatments
are still limited in clinical practice and are mainly supportive
treatment, such as mechanical ventilation and nutritional
support, and etiological treatment.
Emodin, the bio-active compound of Radix rhizoma
Rhei shows multiple pharmacological values, including
anti-inflammatory, anti-fibrosis, anti-tumor proliferation,
anti-atherosclerotic and immunosuppressive effects (Liu et al.,
2011; Pang et al., 2015; Xue, W. H. et al., 2015). Nanosilver,
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FIGURE 2 | Effects of E/S on lethal toxicity (A) and lung inflammation (B) in a CLP-induced sepsis model (n = 10). Balb/c mice were administered E/S (20 mg/1
mg/kg). Lethality was evaluated within 120 h after CLP challenge. E/S significantly decreased the lethality. Immunohistochemistry of endothelial cells (B) revealed that
E/S markedly promoted the endothelial staining and reduced the infiltration of inflammatory cells induced by CLP challenge.
FIGURE 3 | Effects of E/S on lung functions in CLP-induced sepsis (n = 6). Balb/c mice were administered E/S (20 mg/1 mg/kg). The inflammatory cell
numbers (A), IL-8 levels (B), TNF-α levels (C) and LDH release (D) in BALFs increased at 24 h post-CLP challenge in a manner that was inhibited by E/S. ** p < 0.01
vs. Control; ##p < 0.01 vs. CLP.
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FIGURE 4 | Effects of E/S on p38 MAPK (A) and NF-κB (B) in CLP-induced sepsis (n = 6). Balb/c mice were administered E/S (20mg/1mg/kg). p38 MAPK and
NF-κB increased at 24 h post-CLP challenge which was inhibited by E/S or Emodin. **p < 0.05 vs. Control; ##p < 0.01 vs. CLP.
shows robust effects against various microorganisms, at the
same time, it causes intracellular reactive oxygen species (ROS)
generation, DNA damage and apoptosis with a dose-dependent
response over 1µg/ml (Orta-García et al., 2015), which limits
the utilization of nanosilver in vivo. In this study, we found
that combination Emodin with low concentration of nanosilver
(1µg/ml) had the best anti-microbial and anti-adhesive activities.
Anti-adhesive activities of E/S further prevent inflammation by
inhibiting migration and adhesion of various inflammatory cells
and subsequent damage to endothelial and epithelial cells.
In our study, typical and severe pathological alterations
were found in a CLP-induced sepsis model, including notable
inflammatory cell infiltration, interstitial and intra-alveolar
edema and some collapsed alveoli. CLP also significantly
increased total cells, neutrophils and macrophages in BALFs in
mice. And these typical pathological changes were remarkably
improved by E/S treatment or Emodin. Although Emodin
showed protective effects on lung injury, which was consistent
with the results of Yin’s report (Yin et al., 2016), E/S showed a
much stronger inhibition than Emodin, indicating that E/S can
strength the effects of Emodin or nanosilver and weak the toxicity
of nanosilver.
Our results also suggest that the anti-inflammatory property
of E/S possibly results from the inactivation of NF-κB and p38
MAPK signaling pathway, which is consistent with Xue’s report
(Xue J. et al., 2015). LPS, a major outer membrane component
of Gram-negative bacteria, is the main contributing factor to the
development of inflammation by binding with its receptor TLR4,
which activates several signaling cascade including the mitogen
activated protein kinases (MAPKs) such as ERK, p38, and JNK
kinases and NF-κB. p38 MAPK and (or) NF-κB inhibitors
were reported to inhibit LPS-induced sepsis effectively through
multiple pathway (Koch et al., 2012; Chen et al., 2016). Emodin
was reported to protect against concanavalin A-induced hepatitis
in mice through inhibiting activation of the p38 MAPK-NF-κB
signaling pathway (Xue J. et al., 2015), indicating that anti-sepsis
effects of Emodin may be closely related with p38 MAPK-NF-κB
signaling pathway. There are two potential limitations in current
study. First, we revealed protective effects of E/S on sepsis in
mice. However, the in vivo toxicity and pharmacokinetics of E/S
are poorly. Further detailed pharmacokinetics study of E/S in
anti-sepsis trials may be warranted. Second, although the obvious
improvement against sepsis, the detailed molecular mechanism
of E/S on sepsis need further study.
CONCLUSIONS
In conclusion, the E/S have greater antimicrobial effect than
when they apply separately. E/S effectively protected against CLP-
induced sepsis in vitro and in vivo. These beneficial effects may
be the result of two activities, first, anti-microbial activities and
second, suppression of inflammatory activation partly through
NF-κB and p38 MAPK pathway, therefore represent potential
targets of E/S for the prevention and treatment of sepsis.
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